| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |